Bigelow Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $696K | Sell |
4,996
-25
| -0.5% | -$3.5K | 0.28% | 89 |
|
|
2025
Q4 | $616K | Buy |
5,021
+3
| +0.1% | +$365 | 0.24% | 98 |
|
|
2025
Q3 | $557K | Hold |
5,018
| – | – | 0.22% | 102 |
|
|
2025
Q2 | $556K | Sell |
5,018
-500
| -9% | -$53.2K | 0.25% | 98 |
|
|
2025
Q1 | $618K | Buy |
5,518
+425
| +8% | +$43.9K | 0.29% | 89 |
|
|
2024
Q4 | $470K | Sell |
5,093
-25
| -0.5% | -$2.25K | 0.22% | 110 |
|
|
2024
Q3 | $429K | Sell |
5,118
-25
| -0.5% | -$1.91K | 0.19% | 121 |
|
|
2024
Q2 | $353K | Sell |
5,143
-25
| -0.5% | -$1.67K | 0.17% | 129 |
|
|
2024
Q1 | $379K | Hold |
5,168
| – | – | 0.19% | 123 |
|
|
2023
Q4 | $419K | Hold |
5,168
| – | – | 0.23% | 107 |
|
|
2023
Q3 | $387K | Hold |
5,168
| – | – | 0.22% | 107 |
|
|
2023
Q2 | $398K | Sell |
5,168
-250
| -5% | -$19.9K | 0.22% | 110 |
|
|
2023
Q1 | $450K | Hold |
5,418
| – | – | 0.26% | 103 |
|
|
2022
Q4 | $465K | Hold |
5,418
| – | – | 0.27% | 100 |
|
|
2022
Q3 | $334K | Sell |
5,418
-147
| -3% | -$9.27K | 0.2% | 112 |
|
|
2022
Q2 | $344K | Buy |
5,565
+87
| +2% | +$5.39K | 0.19% | 115 |
|
|
2022
Q1 | $326K | Hold |
5,478
| – | – | 0.15% | 121 |
|
|
2021
Q4 | $398K | Sell |
5,478
-100
| -2% | -$6.89K | 0.18% | 109 |
|
|
2021
Q3 | $390K | Sell |
5,578
-95
| -2% | -$6.67K | 0.19% | 105 |
|
|
2021
Q2 | $391K | Hold |
5,673
| – | – | 0.19% | 107 |
|
|
2021
Q1 | $367K | Hold |
5,673
| – | – | 0.19% | 109 |
|
|
2020
Q4 | $331K | Hold |
5,673
| – | – | 0.18% | 112 |
|
|
2020
Q3 | $358K | Hold |
5,673
| – | – | 0.21% | 107 |
|
|
2020
Q2 | $436K | Sell |
5,673
-400
| -7% | -$30.7K | 0.28% | 90 |
|
|
2020
Q1 | $454K | Sell |
6,073
-765
| -11% | -$52.9K | 0.34% | 79 |
|
|
2019
Q4 | $444K | Sell |
6,838
-9
| -0.1% | -$586 | 0.26% | 102 |
|
|
2019
Q3 | $434K | Sell |
6,847
-475
| -6% | -$31.1K | 0.28% | 100 |
|
|
2019
Q2 | $495K | Sell |
7,322
-455
| -6% | -$29.9K | 0.33% | 87 |
|
|
2019
Q1 | $506K | Hold |
7,777
| – | – | 0.35% | 79 |
|
|
2018
Q4 | $486K | Hold |
7,777
| – | – | 0.36% | 79 |
|
|
2018
Q3 | $600K | Hold |
7,777
| – | – | 0.4% | 71 |
|
|
2018
Q2 | $551K | Sell |
7,777
-362
| -4% | -$25.6K | 0.38% | 77 |
|
|
2018
Q1 | $614K | Buy |
8,139
+340
| +4% | +$27K | 0.42% | 69 |
|
|
2017
Q4 | $559K | Buy |
+7,799
| New | +$592K | 0.56% | 51 |
|
Other funds holding GILD
VCM
VPM
Bigelow Investment Advisors's GILD Position: Q1 2026 in Review
Bigelow Investment Advisors reduced its Gilead Sciences (GILD) stake by 0.5% in Q1 2026, selling an estimated $3.5K and leaving 4,996 shares worth $696K. The position accounts for 0.28% of the portfolio, ranked #89.
Bigelow Investment Advisors first reported a position in GILD in Q4 2017 and has held it in 34 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Bigelow Investment Advisors held 4,996 shares of Gilead Sciences worth $696K as of Q1 2026.
- Bigelow Investment Advisors sold 25 Gilead Sciences shares in Q1 2026, an estimated $3.5K.
- Gilead Sciences made up 0.28% of Bigelow Investment Advisors's portfolio in Q1 2026, its #89 holding.
- Bigelow Investment Advisors first reported a position in Gilead Sciences in Q4 2017 and has held it in 34 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Bigelow Investment Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.